683 Capital Management, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,286,000
-3.2%
1,350,000
+74.2%
0.88%
+1.0%
Q1 2023$11,656,000
-21.2%
775,000
-38.0%
0.87%
-30.7%
Q4 2022$14,787,500
-10.3%
1,250,000
-55.1%
1.25%
-1.7%
Q3 2022$16,481,000
+17.5%
2,784,000
-15.6%
1.27%
+28.6%
Q2 2022$14,025,000
-43.3%
3,300,000
+27.0%
0.99%
-25.1%
Q1 2022$24,715,000
+7.8%
2,598,895
+115.3%
1.32%
+56.8%
Q4 2021$22,933,000
-16.8%
1,207,000
+45.7%
0.84%
-21.5%
Q3 2021$27,565,000
+192.1%
828,271
+240.5%
1.08%
+229.8%
Q2 2021$9,436,000
-19.5%
243,2710.0%0.33%
-47.5%
Q1 2021$11,726,000
-43.4%
243,271
-38.9%
0.62%
-36.6%
Q4 2020$20,719,000
+94.4%
398,2710.0%0.98%
+25.5%
Q3 2020$10,658,000
+37.4%
398,2710.0%0.78%
+25.8%
Q2 2020$7,758,000
-1.0%
398,271
-50.0%
0.62%
+34.7%
Q1 2020$7,838,000
+77.3%
796,542
+100.0%
0.46%
-8.9%
Q4 2019$4,421,000
+96.8%
398,271
-0.4%
0.51%
+102.4%
Q3 2019$2,246,000
-47.5%
400,000
-19.2%
0.25%
-35.7%
Q2 2019$4,282,000
+1.4%
495,000
-5.7%
0.39%
+1.6%
Q1 2019$4,221,000
+105.9%
525,000
+5.0%
0.38%
+208.9%
Q4 2018$2,050,000
-26.8%
500,0000.0%0.12%
-31.9%
Q3 2018$2,800,000500,0000.18%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders